In any case, the role of RAS in cerebral aging, AD, PD, and stroke has received increasing attention, given that pharmacological modulation of RAS with ACE inhibitors (ACEIs), AT1R antagonists (ARA-II), or MasR agonists could have benefits beyond blood pressure control [3,48]. Here, MAS1L is linked to Parkinson disease.